## Background: Behavioural and psychological symptoms of dementia (bpsd) cannot be regarded as a single clinical syndrome, but rather as a heterogeneous group of symptoms, each of which can be considered as possible targets for therapy. ## Objective: To compare the efficacy of risperidone and hal
Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia
β Scribed by Guk-Hee Suh; Andrew J. Greenspan; Sung-Ku Choi
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 61 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1693
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Dear Editor I feel I cannot let the assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia (Suh et al., 2006) go unchallenged. This paper shows no such thing. There is a very basic flaw, which means that all findings are invali
## Abstract ## Background Behavioural and psychological symptoms (BPSD) are common during the course of dementia and present severe problems to patients and their caregivers. ## Objectives To assess the therapeutic efficacy and safety of haloperidol and risperidone in treating BPSD in Chinese de
## Abstract ## Objectives To review literature concerning the efficacy, clinical practicability and safety of light treatment for behavioural and psychological symptoms of dementia (BPSD). ## Method Data collection included computer literature searches (MEDLINE, PsycINFO and Cochrane) and checks